S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
The single greatest medical breakthrough of all time? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
NASDAQ:ONCY

Oncolytics Biotech (ONCY) Earnings Date, Estimates & Call Transcripts

$1.55
-0.03 (-1.90%)
(As of 06/9/2023 ET)
Compare
Today's Range
$1.52
$1.59
50-Day Range
$1.11
$2.16
52-Week Range
$0.80
$2.28
Volume
313,585 shs
Average Volume
371,158 shs
Market Capitalization
$99.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Earnings Summary

Upcoming
Earnings Date
Aug. 10Estimated
Actual EPS
(Mar. 3)
-$0.10 Missed By -$0.05
Consensus EPS
(Mar. 3)
-$0.05
Last Year's Q1 EPS
(3/3/2022)
-$0.11
Skip Charts & View Estimated and Actual Earnings Data

ONCY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONCY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Oncolytics Biotech Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.07)($0.07)($0.07)
Q2 20231($0.09)($0.09)($0.09)
Q3 20231($0.07)($0.07)($0.07)
Q4 20231($0.07)($0.07)($0.07)
FY 20234($0.30)($0.30)($0.30)

ONCY Earnings Date and Information

Oncolytics Biotech last issued its earnings results on March 3rd, 2023. The reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.05. Oncolytics Biotech has generated ($0.30) earnings per share over the last year (($0.30) diluted earnings per share). Earnings for Oncolytics Biotech are expected to grow in the coming year, from ($0.33) to ($0.30) per share. Oncolytics Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off prior year's report dates.

Oncolytics Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2023
(Estimated)
        
3/3/2023Q4 2022($0.05)($0.10)($0.05)($0.10)
11/7/2022Q3 2022($0.09)($0.06)+$0.03($0.06)
8/11/2022Q2 2022($0.09)($0.07)+$0.02($0.07)
5/5/2022Q1 2022($0.13)($0.09)+$0.04($0.09)
3/3/2022Q4 2021($0.14)($0.11)+$0.03($0.11)
11/5/20219/30/2021($0.11)($0.07)+$0.04($0.07)    
8/6/2021Q2 2021($0.10)($0.11)($0.01)($0.11)
5/7/2021Q1 2021($0.17)($0.10)+$0.07($0.10)
3/5/2021Q4 2020($0.13)($0.16)($0.03)($0.16)
11/16/20209/30/2020($0.10)($0.16)($0.06)($0.12)  
8/4/2020Q2 2020($0.15)($0.12)+$0.03($0.12)
5/8/2020Q1 2020($0.14)($0.15)($0.01)($0.27)
3/5/2020Q4 2019($0.11)($0.19)($0.08)$0.16
11/12/2019Q3 2019($0.19)($0.12)+$0.07($0.12)
8/13/2019Q2 2019($0.19)($0.19)($0.19)
5/2/2019Q1 2019($0.21)($0.21)($0.21)
3/8/201912/31/2018($0.20)($0.21)($0.01)($0.21)  
11/12/2018Q3($0.19)($0.15)+$0.04($0.15)
8/3/20186/30/2018$0.04($0.21)($0.25)($0.21)
5/11/2018Q1 2018($0.19)($0.19)($0.19)
3/9/2018Q4 2017($0.19)($0.28)($0.09)($0.28)
11/8/2017Q3 2017($0.19)($0.19)($0.19)
8/3/2017Q2 2017($0.19)($0.19)($0.17)
5/5/2017Q1 2017($0.19)($0.19)($0.19)
3/10/2017Q4 2016($0.28)($0.28)($0.28)
11/3/2016Q3 2016($0.19)($0.19)($0.19)
8/4/2016Q2 2016($0.19)($0.19)($0.19)
5/6/2016Q1 2016($0.19)($0.19)($0.19)
3/11/2016Q4 2015($0.19)($0.19)($0.19)
11/5/2015Q3 2015($0.28)($0.28)($0.28)
8/6/2015Q2 2015($0.28)($0.28)($0.28)
5/7/2015Q1 2015($0.57)($0.28)+$0.29($0.28)
3/13/2015Q4 2014($0.47)($0.47)($0.47)
11/6/2014Q3 2014($0.66)($0.47)+$0.19($0.47)
8/7/2014Q2 2014($0.66)($0.47)+$0.19($0.47)
5/8/2014Q1 2014($0.66)($0.57)+$0.09($0.57)
3/13/2014Q4 2013($0.66)($0.76)($0.10)($0.76)
11/7/2013Q3 2013($0.57)($0.66)($0.09)($0.66)
8/1/2013Q2 2013($0.76)($0.57)+$0.19($0.57)
5/9/2013Q1 2013($0.95)($0.76)+$0.19($0.76)












Oncolytics Biotech Earnings - Frequently Asked Questions

When is Oncolytics Biotech's earnings date?

Oncolytics Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off last year's report dates. Learn more on ONCY's earnings history.

Did Oncolytics Biotech beat their earnings estimates last quarter?

In the previous quarter, Oncolytics Biotech (NASDAQ:ONCY) missed the analysts' consensus estimate of ($0.05) by $0.05 with a reported earnings per share (EPS) of ($0.10). Learn more on analysts' earnings estimate vs. ONCY's actual earnings.

How much profit does Oncolytics Biotech generate each year?

Oncolytics Biotech (NASDAQ:ONCY) has a recorded net income of -$19.10 million. ONCY has generated -$0.30 earnings per share over the last four quarters.

What is Oncolytics Biotech's EPS forecast for next year?

Oncolytics Biotech's earnings are expected to grow from ($0.33) per share to ($0.30) per share in the next year.

More Earnings Resources from MarketBeat

This page (NASDAQ:ONCY) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -